WeChat Mini Program
Old Version Features

Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone Versus Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (APOLLO): Extended Follow Up of an Open-Label, Randomised, Multicentre, Phase 3 Trial.

Meletios A. Dimopoulos,Evangelos Terpos,Mario Boccadoro,Sosana Delimpasi,Meral Beksac,Eirini Katodritou,Philippe Moreau,Luca Baldini,Argiris Symeonidis,Jelena Bila,Albert Oriol,Maria -Victoria Mateos,Hermann Einsele,Ioannis Orfanidis,Tobias Kampfenkel,Weiping Liu,Jianping Wang,Michele Kosh,Namphuong Tran,Robin Carson,Pieter Sonneveld

The Lancet Haematology（2023）

Cited 9|Views31
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined